Our study aims to assess the prevalence of CAPA (COVID-19-associated pulmonary
aspergillosis) and describe the associated risk factors and their impact on mortality. A …

Background and objective Invasive pulmonary aspergillosis (IPA) is a frequent complication
among neutropenic patients. It is increasingly being reported in critical coronavirus disease …

COVID-19-associated pulmonary aspergillosis (CAPA) is a life-threatening fungal infection
that mainly affects critically ill patients. The aim of this study was to assess the incidence and …

Background: Critically ill COVID-19 patients have proven to be at risk for developing
invasive fungal infections. However, the incidence and impact of possible/probable COVID …

Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is an
increasingly recognized complication of COVID-19 and is associated with significant over …

Background COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an
invasive fungal disease, often affecting previously immunocompetent, mechanically …

Pulmonary aspergillosis has been reported at high rates in patients with coronavirus
disease 2019 (COVID-19) and is associated with high morbidity and mortality. We …

First reports of cases and case series of COVID-19-associated pulmonary aspergillosis
(CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Background An increasing number of reports have described the COVID‐19–associated
pulmonary aspergillosis (CAPA) as being a further contributing factor to mortality. Based on …